SLN
Silence Therapeutics Plc - ADR

371
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 13,
Pre-Market

Estimated EPS

-$0.19

Estimated Rev

$5.72M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.19
--
--
N/A
Q2 '25
-$0.13
-$0.19
-43.41%
MISSED
Q1 '25
-$0.15
-$0.20
-31.04%
MISSED
Q4 '24
-$0.24
$0.07
131.05%
BEAT
Q3 '24
-$0.13
-$0.24
-91.50%
MISSED

Latest SLN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.